Gayen Sanjib, Kombathula Sri Harsha, Manna Sumanta, Varshney Sonal, Pareek Puneet
Department of Radiation Oncology, All India Institute of Medical Sciences, Jodhpur, India.
Radiat Oncol J. 2020 Jun;38(2):138-147. doi: 10.3857/roj.2020.00143. Epub 2020 May 26.
To evaluate the dosimetric variations in patients of head and neck cancer treated with definitive or adjuvant radiotherapy using optimized non-coplanar (ncVMAT) beams with coplanar (cVMAT) beams using volumetric arc therapy.
Twenty-two patients of head and neck cancer that had received radiotherapy using VMAT in our department were retrospectively analyzed. Each of the patients was planned using coplanar and non-coplanar orientations using an optimized couch angle and fluences. We analyzed the Conformity Index (CIRTOG), Dose Homogeneity Index (DHI), Heterogeneity Index (HIRTOG), low dose volume, target and organs-at-risk coverage in both the plans without changing planning optimization parameters.
The prescription dose ranged from 60 Gy to 70 Gy. Using ncVMAT, CIRTOG, DHI and HIRTOG, and tumor coverage (ID95%) had improved, low dose spillage volume in the body V5Gy was increased and V10Gy was reduced. Integral dose and intensity-modulated radiation therapy factor had increased in ncVMAT. In the case of non-coplanar beam arrangements, maximum dose (Dmax) of right and left humeral head were reduced significantly whereas apex of the right and left lung mean dose were increased.
The use of ncVMAT produced better target coverage and sparing of the shoulder and soft tissue of the neck as well as the critical organ compared with the cVMAT in patients of head and neck malignancy.
使用容积弧形调强放疗,评估采用优化的非共面(ncVMAT)射束联合共面(cVMAT)射束治疗的头颈癌患者的剂量学变化。
回顾性分析了在我院接受VMAT放疗的22例头颈癌患者。每位患者均采用共面和非共面方向,使用优化的治疗床角度和注量进行计划制定。在不改变计划优化参数的情况下,我们分析了两种计划中的适形指数(CIRTOG)、剂量均匀性指数(DHI)、不均匀性指数(HIRTOG)、低剂量体积、靶区和危及器官的覆盖情况。
处方剂量范围为60 Gy至70 Gy。使用ncVMAT时,CIRTOG、DHI和HIRTOG以及肿瘤覆盖率(ID95%)有所改善,身体V5Gy的低剂量溢出体积增加,V10Gy减少。ncVMAT中的积分剂量和调强放疗因子增加。在非共面射束排列的情况下,左右肱骨头的最大剂量(Dmax)显著降低,而左右肺尖的平均剂量增加。
与cVMAT相比,在头颈恶性肿瘤患者中使用ncVMAT可产生更好的靶区覆盖,对头颈肩部软组织以及关键器官的保护效果更佳。